Login / Signup

Water T2 could predict functional decline in patients with dysferlinopathy.

Ursula MooreEricky Caldas de Almeida AraújoHarmen ReyngoudtHeather Gordish-DressmanFiona E SmithIan WilsonMeredith JamesAnna MayhewLaura RufibachJohn W DayKristi J JonesDiana X Bharucha-GoebelEmmanuelle Salort-CampanaAlan PestronkMaggie C WalterCarmen ParadasTanya StojkovicMadoka Mori-YoshimuraElena BravverElena PegoraroJerry R Mendellnull nullKate BushbyAndrew M BlamireVolker StraubPierre G CarlierJordi Díaz-Manera
Published in: Journal of cachexia, sarcopenia and muscle (2022)
could be used to improve prognostication, patient selection, and disease modelling for clinical trials.
Keyphrases
  • clinical trial
  • case report
  • phase ii
  • randomized controlled trial